American Tower (AMT) looks undervalued with stable recurring revenue, a 3.87% yield, and AI/data tailwinds—see why it’s a Buy ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

Young people are facing a mental health crisis. This group of Cincinnati teens thinks they know how to solve it.

The curtains rose on the second edition of the JEC Composite Talks on the 11th of December 2025 at ITC Maratha, Mumbai, ...

Enforcement alone is failing. A new governance model—integrating forensic science, community care, and real-time intelligence ...

BrainScope, a commercial-stage medical neurotechnology company applying AI and deep learning to computational neuroscience to deliver clinically validated, noninvasive digital tools for objective ...

CES 2026 is here. Think of CES like a harbinger of what’s next in technology. Every January, the industry descends upon Las ...

A new discovery about how cells communicate with each other in the body's immune system has revealed deeper insights for an ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...